Exhibit 23.2

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the reference to our firm under the caption "Experts" and to the use of our report dated September 22, 2026, with respect to the financial statements of Ambros Therapeutics, Inc. included in the Registration Statement (Form S-4) and related proxy statement/prospectus of Werewolf Therapeutics, Inc. for the registration of shares of its common stock.

 

/s/ Ernst & Young

San Diego, California

September 22, 2026

---